In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1666 News Items found
In the Lab
Enlarged image of neuroblastoma cell with stains.
Neuroblastoma May Result from DNA Circles Wreaking Havoc on the Genome

Mysterious circular DNA may contribute to neuroblastoma and other childhood cancers.
In the News
A presentation stage at the San Antonio Breast Cancer Symposium.
Updates from SABCS 2019: Detection and Screening, Immunotherapy Advances, and Therapy Resistance

About two dozen MSK physicians and researchers shared their work at the world’s leading breast cancer conference, held annually in San Antonio.
MSK’S Facilities Management Team Create 26th Annual Holiday Hallway at Memorial Sloan Kettering

Memorial Sloan Kettering Cancer Center (MSK) today celebrates its 26th year of the "holiday hallway." Each year during December, MSK’s carpenters, toolmakers, locksmiths, electricians, and painters construct a winter wonderland in the basement hallway of MSK for patients, families, and staff to visit and enjoy. The decades-long tradition brings joy and cheer to all and has grown in size and detail year after year. The “holiday hallway” is a labor of love for MSK’s Facilities staff, who give of themselves to create the magical MSK tradition. 
In the News
Memorial Sloan Kettering medical oncologist Eileen O’Reilly
Year in Review: 10 Important Clinical Research Discoveries in 2019

As we approach the end of 2019, learn about some of the biggest advances in clinical research made this year at MSK.
In the Clinic
Illustration of breast cancer cell
Targeted Drug Shows Promise Against HER2-Positive Breast Cancer That Stops Responding to Other Drugs

MSK medical oncologist Shanu Modi is the lead author of a new paper detailing the results from a phase II trial of a breast cancer drug called trastuzumab deruxtecan or DS-8201a. Results from this study were also presented at the San Antonio Breast Cancer Symposium.
Bringing Hospitality to the Hospital: A Reimagined Patient Experience at the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center

The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center is the latest example of the institution’s creative approach to rethinking the way cancer care is delivered. It will allow Memorial Sloan Kettering Cancer Center (MSK) to enhance patient comfort and convenience while achieving greater efficiencies by providing exceptional care on an outpatient basis. The center was designed after listening closely to feedback from patients and staff, and with insights learned at MSK’s other thoughtfully designed outpatient facilities. From intuitive touch points ahead of arrival, to the moment patients are greeted, to discharge, the experience is curated to more resemble a calming hospitality environment than a hospital.
Innovative Research and Comprehensive Clinical Care at the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center

The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center will be home to the largest gathering of hematologic experts ever at Memorial Sloan Kettering Cancer Center (MSK), including specialists in blood and marrow stem cell transplants, chimeric antigen receptor T cell therapy, lymphoma, leukemia, multiple myeloma, and nonmalignant blood disorders.
State-of-the-Art Structural Resiliency and Environmental Sustainability at the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center

The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center sets a new benchmark for sustainability and resiliency in a healthcare facility.
In the News
Micrograph of multiple myeloma cells
MSK Experts Report New Findings about Multiple Myeloma at the 2019 ASH Meeting

Two studies on multiple myeloma provide new information about diagnosing and treating this blood cancer.
In the News
Exterior shot of building at ASH meeting
MSK Experts Report Advances in Lymphoma Treatment at the 2019 ASH Meeting

Learn more about the work of MSK lymphoma researchers being presented at the 2019 meeting of the American Society of Hematology.